HomeCompareSAEOF vs MRK

SAEOF vs MRK: Dividend Comparison 2026

SAEOF yields 55.56% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAEOF wins by $465.9K in total portfolio value
10 years
SAEOF
SAEOF
● Live price
55.56%
Share price
$3.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$522.7K
Annual income
$115,105.08
Full SAEOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SAEOF vs MRK

📍 SAEOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAEOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAEOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAEOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAEOF
Annual income on $10K today (after 15% tax)
$4,722.22/yr
After 10yr DRIP, annual income (after tax)
$97,839.32/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SAEOF beats the other by $89,510.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAEOF + MRK for your $10,000?

SAEOF: 50%MRK: 50%
100% MRK50/50100% SAEOF
Portfolio after 10yr
$289.7K
Annual income
$62,451.61/yr
Blended yield
21.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SAEOF
No analyst data
Altman Z
0.0
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAEOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAEOFMRK
Forward yield55.56%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$522.7K$56.8K
Annual income after 10y$115,105.08$9,798.13
Total dividends collected$426.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SAEOF vs MRK ($10,000, DRIP)

YearSAEOF PortfolioSAEOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,256$5,555.56$11,206$366.19+$5.0KSAEOF
2$25,834$8,440.06$12,650$502.35+$13.2KSAEOF
3$40,177$12,535.55$14,407$694.19+$25.8KSAEOF
4$61,210$18,220.40$16,585$967.82+$44.6KSAEOF
5$91,438$25,942.77$19,342$1,363.89+$72.1KSAEOF
6$134,057$36,218.79$22,913$1,947.19+$111.1KSAEOF
7$193,068$49,626.62$27,662$2,823.89+$165.4KSAEOF
8$273,379$66,796.05$34,159$4,173.35+$239.2KSAEOF
9$380,909$88,393.78$43,337$6,308.80+$337.6KSAEOF
10$522,678$115,105.08$56,776$9,798.13+$465.9KSAEOF

SAEOF vs MRK: Complete Analysis 2026

SAEOFStock

Sanden Corporation, together with its subsidiaries, manufactures and sells automotive equipment systems in Japan and internationally. It offers automotive air-conditioning systems, including system products, condensers, evaporators, heater cores, electric coolant heaters, pipes for air conditioning, and intercoolers, as well as heating, ventilating and air-conditioning units. The company also provides compressor products for automotive air conditioning, such as electric, swash plate and wobble plate type variable displacement, wobble and scroll plate type fixed displacement, and CO2 compressors. In addition, it provides living and environment systems. The company was formerly known as Sanden Holdings Corporation and changed its name to Sanden Corporation in January 2022. The company was founded in 1943 and is headquartered in Isesaki, Japan. Sanden Corporation is a subsidiary of Hisense Japan Automotive Air-Conditioning Systems Corporation.

Full SAEOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SAEOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAEOF vs SCHDSAEOF vs JEPISAEOF vs OSAEOF vs KOSAEOF vs MAINSAEOF vs JNJSAEOF vs ABBVSAEOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.